Market Cap | 7.62B | P/E | - | EPS this Y | -2,200.00% | Ern Qtrly Grth | - |
Income | -40M | Forward P/E | 75.92 | EPS next Y | 200.00% | 50D Avg Chg | 6.00% |
Sales | 2.38B | PEG | 26.99 | EPS past 5Y | -78.50% | 200D Avg Chg | 27.00% |
Dividend | N/A | Price/Book | 2.78 | EPS next 5Y | -2.50% | 52W High Chg | -33.00% |
Recommedations | 2.90 | Quick Ratio | 1.53 | Shares Outstanding | 422.11M | 52W Low Chg | 172.00% |
Insider Own | 1.19% | ROA | 2.90% | Shares Float | 293.43M | Beta | 0.85 |
Inst Own | 97.99% | ROE | -1.44% | Shares Shorted/Prior | 15.69M/14.52M | Price | 18.22 |
Gross Margin | 20.45% | Profit Margin | -1.68% | Avg. Volume | 2,713,522 | Target Price | 14.54 |
Oper. Margin | 8.81% | Earnings Date | Nov 2 | Volume | 4,496,167 | Change | 3.23% |
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. The company was incorporated in 2003 and is headquartered in Murray, Utah.
Cantor Fitzgerald | Neutral | Aug 20, 24 |
Truist Securities | Hold | Aug 8, 24 |
TD Cowen | Hold | Aug 5, 24 |
Leerink Partners | Market Perform | Aug 1, 24 |
Canaccord Genuity | Buy | Jul 22, 24 |
Deutsche Bank | Hold | Jul 9, 24 |
Morgan Stanley | Overweight | Jul 8, 24 |
Baird | Outperform | Jul 2, 24 |
Cantor Fitzgerald | Overweight | Jul 2, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Evans Richard B. Jr. | Principal Accounting.. Principal Accounting Officer | Jun 09 | Sell | 16.76 | 29,000 | 486,040 | 124,007 | 06/12/23 |
SPARBY JOHN M. | President President | May 10 | Sell | 16.364 | 20,000 | 327,280 | 243,827 | 05/12/23 |
RIVAS LEE | Chief Executive Offi.. Chief Executive Officer | Feb 21 | Buy | 13.934 | 71,767 | 1,000,001 | 71,767 | 02/21/23 |
SPARBY JOHN M. | See Remarks See Remarks | Aug 19 | Sell | 25.007 | 40,000 | 1,000,280 | 123,772 | 08/23/22 |
FLANAGAN JOSEPH GERARD | Chief Executive Offi.. Chief Executive Officer | Aug 16 | Option | 2.42 | 600,000 | 1,452,000 | 2,992,221 | 08/18/22 |
FLANAGAN JOSEPH GERARD | Chief Executive Offi.. Chief Executive Officer | Aug 16 | Sell | 25.27 | 600,000 | 15,162,000 | 2,792,221 | 08/18/22 |
LONG GARY STEVEN | See Remarks See Remarks | Aug 10 | Option | 3.75 | 57,964 | 217,365 | 285,590 | 08/12/22 |
LONG GARY STEVEN | See Remarks See Remarks | Aug 10 | Sell | 26.01 | 202,999 | 5,280,004 | 82,591 | 08/12/22 |
Evans Richard B. Jr. | Principal Accounting.. Principal Accounting Officer | Aug 10 | Sell | 25.72 | 40,000 | 1,028,800 | 125,876 | 08/12/22 |
SPARBY JOHN M. | See Remarks See Remarks | Aug 09 | Sell | 25.94 | 29,056 | 753,713 | 163,772 | 08/11/22 |
Feiner Michael C. | Director Director | Aug 05 | Sell | 26.181 | 10,318 | 270,136 | 34,066 | 08/09/22 |
SPARBY JOHN M. | See Remarks See Remarks | Aug 05 | Option | 2.42 | 48,047 | 116,274 | 240,875 | 08/09/22 |
SPARBY JOHN M. | See Remarks See Remarks | Aug 05 | Sell | 26.84 | 48,047 | 1,289,581 | 192,828 | 08/09/22 |
Evans Richard B. Jr. | Principal Accounting.. Principal Accounting Officer | Aug 08 | Sell | 26.772 | 10,000 | 267,720 | 165,876 | 08/09/22 |
FLANAGAN JOSEPH GERARD | President and CEO President and CEO | Oct 12 | Option | 2.42 | 130,517 | 315,851 | 2,531,451 | 10/14/21 |
FLANAGAN JOSEPH GERARD | President and CEO President and CEO | Oct 12 | Sell | 23.09 | 130,517 | 3,013,638 | 2,510,336 | 10/14/21 |
SPARBY JOHN M. | Chief Operating Offi.. Chief Operating Officer | Feb 24 | Option | 3.85 | 10,461 | 40,275 | 310,854 | 02/24/21 |
SPARBY JOHN M. | Chief Operating Offi.. Chief Operating Officer | Feb 24 | Sell | 28.21 | 100,461 | 2,834,005 | 210,393 | 02/24/21 |